Clinical Trial Update: ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM) [Phase 1, Phase 2]

View source ↗

Summary

The document describes a Phase 1/2 clinical trial evaluating autologous stem cell transplant (ASCT) in combination with the CAR-T therapy C-CAR088 for ultra hig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• C-CAR088

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: RECRUITING